Day: February 4, 2021

For individuals living with blood cancer, stem cell transplantation can offer a potential cure. Over the last decade, survival rates for patients who receive such transplants have been improving. However, for a small group of these patients, an allogenic stem cell transplantation may result in another disease called graft-vs-host disease (GVHD), a potentially fatal complication that can appear after stem cell transplantation. GVHD, which can be an acute or chronic condition, marks the start of an unexpected journey for these patients and their caregivers. It is with this in mind…